Financials
- Market Capitalization 152.11 M
- Employee 91
- Founded 1998
- CEO N/A
- Website www.maxcyte.com
- Headquarter Delaware, United States
- FIGI BBG00R1W85V4
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3708 | APYX Apyx Medical Corporation - Common Stock | 4.24 USD | -0.47% | +0.95% | -11.11% | +119.69% | 177.55 M USD | ||
| 3729 | INGN Inogen, Inc - Common Stock | 6.33 USD | -3.21% | -3.21% | -1.86% | -28.68% | 171.38 M USD | ||
| 3849 | CVRX CVRx, Inc. - Common Stock | 5.17 USD | -4.79% | -9.93% | -1.34% | -30.23% | 137.19 M USD | ||
| 3891 | RCEL Avita Medical, Inc. - Common Stock | 4.01 USD | +1.52% | -19.80% | +1.52% | -31.80% | 123.41 M USD |
Frequently asked questions about MaxCyte, Inc. - Common Stock
What is the MaxCyte, Inc. - Common Stock stock price today?
The current price of MaxCyte, Inc. - Common Stock (MXCT) is 1.42. Over the past 24 hours, the stock has changed by +2.90%. Follow the MXCT chart for real-time price dynamics.
What is the stock ticker of MaxCyte, Inc. - Common Stock?
MaxCyte, Inc. - Common Stock trades under the ticker MXCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MaxCyte, Inc. - Common Stock stock going up?
MXCT has changed by +10.08% over the last week, +24.56% over the last month, and -37.17% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MaxCyte, Inc. - Common Stock net income for the last quarter?
MaxCyte, Inc. - Common Stock reported net income of -4.75 M for the last quarter. The previous quarter showed -9.6 M, which means net income changed by +50.50%.
How many employees does MaxCyte, Inc. - Common Stock have?
As of the latest available data, MaxCyte, Inc. - Common Stock has 91 employees. Workforce size can provide additional context about the company's scale and operations.
What is MaxCyte, Inc. - Common Stock EBITDA?
MaxCyte, Inc. - Common Stock EBITDA is -5.14 M, and its EBITDA margin is -53.24%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MaxCyte, Inc. - Common Stock stock?
You can buy MaxCyte, Inc. - Common Stock (MXCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MaxCyte, Inc. - Common Stock stock?
Investing in MaxCyte, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MXCT chart and related analysis on metatrader.com as part of your research.